Deutsche Bank’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$113K Sell
39,031
-1,006
-3% -$2.91K ﹤0.01% 3196
2025
Q1
$86.1K Sell
40,037
-4,015
-9% -$8.63K ﹤0.01% 3214
2024
Q4
$170K Sell
44,052
-238,010
-84% -$921K ﹤0.01% 3101
2024
Q3
$1.85M Buy
282,062
+7,486
+3% +$49K ﹤0.01% 1772
2024
Q2
$1.99M Buy
274,576
+2,652
+1% +$19.2K ﹤0.01% 1617
2024
Q1
$2.06M Sell
271,924
-449
-0.2% -$3.41K ﹤0.01% 1619
2023
Q4
$1.24M Buy
+272,373
New +$1.24M ﹤0.01% 1873
2023
Q3
Sell
-255,593
Closed -$800K 3697
2023
Q2
$800K Hold
255,593
﹤0.01% 2100
2023
Q1
$1.16M Buy
+255,593
New +$1.16M ﹤0.01% 1998
2020
Q1
Sell
-1,468
Closed -$19K 4329
2019
Q4
$19K Sell
1,468
-2,945
-67% -$38.1K ﹤0.01% 4141
2019
Q3
$39K Sell
4,413
-33,792
-88% -$299K ﹤0.01% 3924
2019
Q2
$545K Buy
38,205
+14,050
+58% +$200K ﹤0.01% 3198
2019
Q1
$792K Buy
24,155
+15,825
+190% +$519K ﹤0.01% 3121
2018
Q4
$494K Sell
8,330
-5,472
-40% -$325K ﹤0.01% 3294
2018
Q3
$1.94M Buy
13,802
+5,726
+71% +$803K ﹤0.01% 2868
2018
Q2
$992K Buy
8,076
+6,350
+368% +$780K ﹤0.01% 3397
2018
Q1
$154K Sell
1,726
-16,808
-91% -$1.5M ﹤0.01% 4173
2017
Q4
$1.03M Sell
18,534
-12,886
-41% -$714K ﹤0.01% 3128
2017
Q3
$1.33M Buy
31,420
+5,593
+22% +$236K ﹤0.01% 2780
2017
Q2
$1.09M Buy
25,827
+10,496
+68% +$442K ﹤0.01% 2936
2017
Q1
$855K Buy
15,331
+10,836
+241% +$604K ﹤0.01% 2708
2016
Q4
$170K Buy
4,495
+373
+9% +$14.1K ﹤0.01% 3611
2016
Q3
$162K Sell
4,122
-13,168
-76% -$518K ﹤0.01% 3591
2016
Q2
$1.24M Buy
17,290
+491
+3% +$35.2K ﹤0.01% 2704
2016
Q1
$1.35M Buy
16,799
+482
+3% +$38.6K ﹤0.01% 2597
2015
Q4
$1.23M Buy
16,317
+7,128
+78% +$537K ﹤0.01% 2703
2015
Q3
$3.52M Buy
9,189
+7,001
+320% +$2.68M ﹤0.01% 2047
2015
Q2
$907K Buy
2,188
+345
+19% +$143K ﹤0.01% 2975
2015
Q1
$875K Sell
1,843
-1,764
-49% -$837K ﹤0.01% 2898
2014
Q4
$1.33M Buy
3,607
+18
+0.5% +$6.65K ﹤0.01% 2958
2014
Q3
$845K Buy
+3,589
New +$845K ﹤0.01% 3086